The global neovaginal surgery market size is expected to reach USD 1.4 billion by 2027 registering a CAGR of 3.63%. Supportive insurance and government reimbursement policies for the surgery and social acceptance of transgender individuals are the key factors driving the global market. Researchers focus on designing new alternatives for a skin graft for use in neovaginal construction as innovations enable performing the treatment faster and at a lesser cost than conventional surgery methods.
In April 2017, the Federal University of Ceara (UFC), Brazil, performed an unprecedented procedure, neovaginoplasty, on a 23-year-old woman suffering from MRKH syndrome (vaginal agenesis). The revolutionary surgery method included the use of the skin of tilapia fish for creating a new vaginal canal. Sex Reassignment Surgery (SRS) is expected to be the fastest-growing treatment segment from 2020 to 2027 due to the increasing demand for these surgeries.
For instance, according to the International Medical Tourism Center, around 70% of SRS conducted in Spain are Male-to-Female (MtF) surgeries. Increasing awareness and availability of surgeries, such as neovaginal reconstruction, have led to major workplace-related changes and the provision of insurance coverage for same-sex individuals. In 2016, IBM announced health insurance for same-sex partners including SRS. Thus, various employers offering medical insurance for neovaginal reconstruction surgeries, such as SRS, is expected to boost the market growth.
This product will be delivered within 1-3 business days.
For instance, according to the International Medical Tourism Center, around 70% of SRS conducted in Spain are Male-to-Female (MtF) surgeries. Increasing awareness and availability of surgeries, such as neovaginal reconstruction, have led to major workplace-related changes and the provision of insurance coverage for same-sex individuals. In 2016, IBM announced health insurance for same-sex partners including SRS. Thus, various employers offering medical insurance for neovaginal reconstruction surgeries, such as SRS, is expected to boost the market growth.
Neovaginal Surgery Market Report Highlights
- Major companies have adopted innovative marketing strategies and have entered into long-term agreements with Group Purchasing Organizations (GPOs) for business expansion
- Europe held the largest product revenue share in 2019 owing to increased social awareness and acceptance of gender reassignment in the region
- The number of surgical procedures and techniques is rapidly increasing, thereby driving the demand for products including vaginal stents, dilators, and laparoscopic neovaginal surgery kits
- Asia Pacific is projected to be the fastest-growing regional market during the forecast period
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Report Scope and Objectives1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.1.2 Purchased Database
2.1.3 Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information Or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.4.1.1 Approach 1: Commodity Flow Approach
2.4.2 Volume Price Analysis
2.4.2.1 Approach 2: Volume Price Analysis
2.5 List Of Secondary Sources
2.6 List Of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Treatment Type
3.2.2 Product
3.3 Regional Outlook
3.4 Competitive Insights
Chapter 4 Neovaginal Surgery Market: Industry Outlook
4.1 Market Dynamics
4.1.1 Market Driver Analysis
4.1.1.1 Increase In The Number Of Gender Confirmation Surgeries
4.1.1.2 Availability Of Insurance
4.1.2 Market Restraint Analysis
4.1.2.1 Product Recall
4.2 Penetration & Growth Prospect Mapping
4.2.1 Analysis
4.3 Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat Of New Entrants: Moderate
4.3.1.2 Bargaining Power Of Buyers: Low
4.3.1.3 Competitive Rivalry: Moderate
4.3.1.4 Threat Of Substitutes: Moderate
4.3.1.5 Bargaining Power Of Suppliers: High
4.3.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
4.3.2.1 Political & Legal
4.3.2.2 Economic
4.3.2.3 Technological
4.4 Covid-19 Impact Analysis
4.5 Neovaginal Surgery: Public Hospitals Vs. Private Hospitals
4.6 Reimbursement Scenario
Chapter 5 Neovaginal Surgery Market: Treatment Type Analysis
5.1 Neovaginal Surgery Market: Treatment Type Movement Analysis
5.1.1 Vaginal Agenesis Treatment
5.1.1.1 Vaginal Agenesis Treatment Market, 2016 - 2027 (USD Million)
5.1.2 Vaginal Atresia Treatment
5.1.2.1 Vaginal Atresia Treatment Market, 2016 - 2027 (USD Million)
5.1.2.2 Mcindoe Technique
5.1.2.2.1 Mcindoe Technique Market, 2016 - 2027 (USD Million)
5.1.2.3 Vecchietti Technique
5.1.2.3.1 Vecchietti Technique Market, 2016 - 2027 (USD Million)
5.1.3 Sex Reassignment Surgery
5.1.3.1 Sex Reassignment Surgery Market, 2016 - 2027 (USD Million)
Chapter 6 Neovaginal Surgery Market: Product Analysis
6.1 Neovaginal Surgery Market: Product Movement Analysis
6.1.1 Vaginal Dilators
6.1.1.1 Vaginal Dilators Market, 2016 - 2027 (USD Million)
6.1.2 Vaginal Stents
6.1.2.1 Vaginal Stents Market, 2016 - 2027 (USD Million)
6.1.3 Laparoscopic Neovaginal Surgeries Kits
6.1.3.1 Laparoscopic Neovaginal Surgeries Kits Market, 2016 - 2027 (USD Million)
6.2 Pricing Analysis, 2019
6.2.1 Vaginal Dilators And Stents Costs
6.2.2 Laparoscopic Neovaginal Surgeries Kits
Chapter 7 Regional Outlook
7.1 Neovaginal Surgery Market Share By Region, 2019 & 2027
7.2 North America
7.2.1 North America Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.2.2 North America Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.2.3 The U.S.
7.2.3.1 The U.S. Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.2.3.2 The U.S. Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.2.4 Canada
7.2.4.1 Canada Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.2.4.2 Canada Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Europe Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.2 Europe Neovaginal Surgery Market, By Product Type, 2016 - 2027 (USD Million)
7.3.3 The U.K.
7.3.3.1 The U.K. Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.3.2 The U.K. Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.3.4 Germany
7.3.4.1 Germany Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.4.2 Germany Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.3.5 France
7.3.5.1 France Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.5.2 France Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.3.6 Italy
7.3.6.1 Italy Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.6.2 Italy Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.3.7 Spain
7.3.7.1 Spain Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.3.7.2 Spain Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.2 Asia Pacific Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.3.2 Japan Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4.4 China
7.4.4.1 China Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.4.2 China Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4.5 India
7.4.5.1 India Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.5.2 India Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4.6 Thailand
7.4.6.1 Thailand Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.6.2 Thailand Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.4.7 Indonesia
7.4.7.1 Indonesia Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.4.7.2 Indonesia Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.5.2 Latin America Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.5.3.2 Brazil Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.5.4.2 Mexico Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.5.5 Argentina
7.5.5.1 Argentina Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.5.5.2 Argentina Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.6 Mea
7.6.1 Mea Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.6.2 Mea Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
7.6.3 South Africa
7.6.3.1 South Africa Neovaginal Surgery Market, By Treatment Type, 2016 - 2027 (USD Million)
7.6.3.2 South Africa Neovaginal Surgery Market, By Product, 2016 - 2027 (USD Million)
Chapter 8 Competitive Landscape
8.1 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.2 Vendor Landscape
8.2.1 List Of Distributors
8.2.2 List Of Service Providers
8.2.3 Company Market Position Analysis, 2019
8.3 Company Profiles
8.3.1 Major Manufacturers
8.3.1.1 Vuvatech
8.3.1.1.1 Company Overview
8.3.1.1.2 Financial Performance
8.3.1.1.3 Product Benchmarking
8.3.1.1.4 Strategic Initiatives
8.3.1.2 Bioteque America, Inc.
8.3.1.2.1 Company Overview
8.3.1.2.2 Financial Performance
8.3.1.2.3 Product Benchmarking
8.3.1.3 Floravi
8.3.1.3.1 Company Overview
8.3.1.3.2 Product Benchmarking
8.3.1.4 Coopersurgical, Inc.
8.3.1.4.1 Company Overview
8.3.1.4.2 Financial Performance
8.3.1.4.3 Product Benchmarking
8.3.1.5 Owen Mumford Ltd.
8.3.1.5.1 Company Overview
8.3.1.5.2 Financial Performance
8.3.1.5.3 Product Benchmarking
8.3.1.6 Kessel Medintim Gmbh
8.3.1.6.1 Company Overview
8.3.1.6.2 Financial Performance
8.3.1.6.3 Product Benchmarking
8.3.1.7 Advin Health Care
8.3.1.7.1 Company Overview
8.3.1.7.2 Financial Performance
8.3.1.7.3 Product Benchmarking
8.3.1.8 Karl Storz
8.3.1.8.1 Company Overview
8.3.1.8.2 Financial Performance
8.3.1.8.3 Product Benchmarking
8.3.1.8.4 Strategic Initiatives
8.3.1.9 Soul Source Therapeutic Devices, Inc.
8.3.1.9.1 Company Overview
8.3.1.9.2 Financial Performance
8.3.1.9.3 Product Benchmarking
8.3.1.10 Mdti Company Ltd.
8.3.1.10.1 Company Overview
8.3.1.10.2 Financial Performance
8.3.1.10.3 Product Benchmarking
8.3.1.11 Marina Medical, Inc.
8.3.1.11.1 Company Overview
8.3.1.11.2 Financial Performance
8.3.1.11.3 Product Benchmarking
8.3.2 Major Clinics/Hospitals
8.3.2.1 London Transgender Clinic
8.3.2.1.1 Company Overview
8.3.2.1.2 Service Benchmarking
8.3.2.2 Phuket Plastic Surgery Institute
8.3.2.2.1 Company Overview
8.3.2.2.2 Service Benchmarking
8.3.2.2.3 Strategic Initiatives
8.3.2.3 Icahn School Of Medicine At Mount Sinai
8.3.2.3.1 Company Overview
8.3.2.3.2 Financial Performance
8.3.2.3.3 Service Benchmarking
8.3.2.3.4 Strategic Initiatives
8.3.2.4 Cedars-Sinai
8.3.2.4.1 Company Overview
8.3.2.4.2 Financial Performance
8.3.2.4.3 Service Benchmarking
8.3.2.4.4 Strategic Initiatives
8.3.2.5 Nationwide Children’s Hospital
8.3.2.5.1 Company Overview
8.3.2.5.2 Financial Performance
8.3.2.5.3 Service Benchmarking
8.3.2.5.4 Strategic Initiatives
8.3.2.6 Ann & Robert H. Lurie Children's Hospital Of Chicago
8.3.2.7 Company Overview
8.3.2.7.1 Financial Performance
8.3.2.7.2 Service Benchmarking
8.3.2.8 Chettawut Plastic Surgery Center
8.3.2.8.1 Company Overview
8.3.2.8.2 Service Benchmarking
8.3.2.9 Tips
8.3.2.9.1 Company Overview
8.3.2.9.2 Financial Performance
8.3.2.9.3 Service Benchmarking
8.3.2.10 González-Fontana
8.3.2.10.1 Company Overview
8.3.2.10.2 Service Benchmarking
8.3.2.11 Oasis Skin Clinic
8.3.2.11.1 Company Overview
8.3.2.11.2 Service Benchmarking
Chapter 9 Kol Commentary
9.1 Kol Comments
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Comparison of surgical procedures for vaginal atresia treatment
Table 4 Country-wise price comparison of vaginal dilators and stents
Table 5 List of prices for key products offered by prominent market players
Table 6 Country-wise price comparison of various laparoscopic neovaginal surgery kitsList of Figures
FIG. 1 Neovaginal surgery market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2019 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Health insurance coverage in the U.S., 2016
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping
FIG. 15 Neovaginal surgery market: Treatment type movement analysis (USD Million)
FIG. 16 Neovaginal surgery market treatment type outlook: Key takeaways (USD Million)
FIG. 17 Vaginal agenesis treatment market 2016 - 2027 (USD Million)
FIG. 18 Vaginal atresia treatment market 2016 - 2027 (USD Million)
FIG. 19 McIndoe technique market 2016 - 2027 (USD Million)
FIG. 20 Vecchietti technique market 2016 - 2027 (USD Million)
FIG. 21 Sex reassignment surgery market, 2016 - 2027 (USD Million)
FIG. 22 Neovaginal surgery market: Product movement analysis (USD Million)
FIG. 23 Neovaginal surgery market treatment product outlook: Key takeaways (USD Million)
FIG. 24 Dilators market 2016 - 2027 (USD Million)
FIG. 25 Vaginal stents market, 2016 - 2027 (USD Million)
FIG. 26 Laparoscopic neovaginal surgeries kits market, 2016 - 2027 (USD Million)
FIG. 27 Regional marketplace: Treatment type key takeaways
FIG. 28 Regional marketplace: Product key takeaways
FIG. 29 Regional outlook, by treatment type, 2019 & 2027 (USD Million)
FIG. 30 Regional outlook, by product, 2019 & 2027 (USD Million)
FIG. 31 North America neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 32 North America neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 33 The U.S. neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 34 The U.S. neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 35 Canada neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 36 Canada neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 37 Europe neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 38 Europe neovaginal surgery market, by product type, 2016 - 2027 (USD Million)
FIG. 39 The U.K. neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 40 The U.K. neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 41 Germany neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 42 Germany neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 43 France neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 44 France neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 45 Italy neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 46 Italy neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 47 Spain neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 48 Spain neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 49 Asia Pacific neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 50 Asia Pacific neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 51 Japan neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 52 Japan neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 53 China neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 54 China neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 55 India neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 56 India neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 57 Thailand neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 58 Thailand neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 59 Indonesia neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 60 Indonesia neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 61 Latin America neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 62 Latin America neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 63 Brazil neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 64 Brazil neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 65 Mexico neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 66 Mexico neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 67 Argentina neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 68 Argentina neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 69 MEA neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 70 MEA neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 71 South Africa neovaginal surgery market, by treatment type, 2016 - 2027 (USD Million)
FIG. 72 South Africa neovaginal surgery market, by product, 2016 - 2027 (USD Million)
FIG. 73 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
FIG. 74 Company market position analysis
Companies Mentioned
- Vuvatech
- Bioteque America, Inc.
- Floravi
- Coopersurgical, Inc.
- Owen Mumford Ltd.
- Kessel Medintim Gmbh
- Advin Health Care
- Karl Storz
- Soul Source Therapeutic Devices, Inc.
- Mdti Company Ltd.
- Marina Medical, Inc.
- London Transgender Clinic
- Phuket Plastic Surgery Institute
- Icahn School Of Medicine At Mount Sinai
- Cedars-Sinai
- Nationwide Children’s Hospital
- Ann & Robert H. Lurie Children's Hospital Of Chicago
- Chettawut Plastic Surgery Center
- Tips
- González-Fontana
- Oasis Skin Clinic
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | January 2021 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 1.11 Billion |
| Forecasted Market Value ( USD | $ 1.4 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
